Long-Acting β-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial.
暂无分享,去创建一个
F. Martinez | P. Calverley | R. Brook | B. Celli | J. Vestbo | J. Yates | D. Newby | C. Crim | Julie A. Anderson | A. P. Holmes | Summit Investigators